ArticleAlzheimer's research & therapy2026

Longitudinal plasma p-tau217 as a marker for tracking progression and predicting cognitive decline in Alzheimer's disease.

Jehyun Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.